{"title":"凝血酶在中枢神经系统活动和中风中的作用。","authors":"Ancuţa-Maria Pleşeru, Romeo Gabriel Mihailă","doi":"10.15386/cjmed-973","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Thrombin is a key factor of hemostasis, mediating the conversion of fibrinogen into fibrin. Along with prothrombin, of which thrombin is the active derivative, it has been found locally expressed in the central nervous system. This article aims to describe the role of thrombin in the normal functioning of the central nervous system and stroke.</p><p><strong>Methods: </strong>In this mini-review, the specialized databases Medscape, PubMed, and Web of Science, from the years 2003-2018, were used to find relevant documents by using MeSH terms: \"thrombin\" and \"stroke\".</p><p><strong>Results: </strong>Prothrombin and thrombin influence neural development, protection and regeneration, thrombin being a relatively strong regulating factor of brain function. However, high levels of thrombin are detrimental to neuronal health, and cause atherosclerotic plaque development and instability - a leading cause of cerebral infarction. In stroke, thrombin promotes direct cellular toxicity, vascular disruption, oxidative stress and inflammatory response. There is a direct correlation between thrombin activity in the affected brain hemisphere and the infarction volume. Direct acting thrombin inhibitors, like dabigatran, significantly decrease the risk of ischemic stroke.</p><p><strong>Conclusion: </strong>Further studies on the correlation between thrombin levels, generation and activity and the risk and recurrence of ischemic cerebral stroke should give new insight on this association, resulting in an optimized practical therapeutic approach.</p>","PeriodicalId":91233,"journal":{"name":"Clujul medical (1957)","volume":"91 4","pages":"368-371"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8c/ca/cm-91-368.PMC6296729.pdf","citationCount":"6","resultStr":"{\"title\":\"The role of thrombin in central nervous system activity and stroke.\",\"authors\":\"Ancuţa-Maria Pleşeru, Romeo Gabriel Mihailă\",\"doi\":\"10.15386/cjmed-973\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Thrombin is a key factor of hemostasis, mediating the conversion of fibrinogen into fibrin. Along with prothrombin, of which thrombin is the active derivative, it has been found locally expressed in the central nervous system. This article aims to describe the role of thrombin in the normal functioning of the central nervous system and stroke.</p><p><strong>Methods: </strong>In this mini-review, the specialized databases Medscape, PubMed, and Web of Science, from the years 2003-2018, were used to find relevant documents by using MeSH terms: \\\"thrombin\\\" and \\\"stroke\\\".</p><p><strong>Results: </strong>Prothrombin and thrombin influence neural development, protection and regeneration, thrombin being a relatively strong regulating factor of brain function. However, high levels of thrombin are detrimental to neuronal health, and cause atherosclerotic plaque development and instability - a leading cause of cerebral infarction. In stroke, thrombin promotes direct cellular toxicity, vascular disruption, oxidative stress and inflammatory response. There is a direct correlation between thrombin activity in the affected brain hemisphere and the infarction volume. Direct acting thrombin inhibitors, like dabigatran, significantly decrease the risk of ischemic stroke.</p><p><strong>Conclusion: </strong>Further studies on the correlation between thrombin levels, generation and activity and the risk and recurrence of ischemic cerebral stroke should give new insight on this association, resulting in an optimized practical therapeutic approach.</p>\",\"PeriodicalId\":91233,\"journal\":{\"name\":\"Clujul medical (1957)\",\"volume\":\"91 4\",\"pages\":\"368-371\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8c/ca/cm-91-368.PMC6296729.pdf\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clujul medical (1957)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15386/cjmed-973\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/10/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clujul medical (1957)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15386/cjmed-973","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/10/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
摘要
背景:凝血酶是止血的关键因子,介导纤维蛋白原向纤维蛋白的转化。它与凝血酶原(凝血酶是其活性衍生物)一起在中枢神经系统局部表达。本文旨在描述凝血酶在中枢神经系统和中风的正常功能中的作用。方法:在这篇小型综述中,使用专业数据库Medscape、PubMed和Web of Science 2003-2018年的相关文献,使用MeSH术语:“凝血酶”和“卒中”来查找相关文献。结果:凝血酶原和凝血酶影响神经发育、保护和再生,凝血酶是一种较强的脑功能调节因子。然而,高水平的凝血酶对神经元健康有害,并导致动脉粥样硬化斑块的发展和不稳定,这是脑梗死的主要原因。在中风中,凝血酶直接促进细胞毒性、血管破坏、氧化应激和炎症反应。在受累脑半球的凝血酶活性与梗死体积之间有直接的相关性。直接作用凝血酶抑制剂,如达比加群,可显著降低缺血性中风的风险。结论:进一步研究凝血酶水平、生成和活性与缺血性脑卒中风险和复发的相关性,有助于对这种相关性有新的认识,从而优化实用的治疗方法。
The role of thrombin in central nervous system activity and stroke.
Background: Thrombin is a key factor of hemostasis, mediating the conversion of fibrinogen into fibrin. Along with prothrombin, of which thrombin is the active derivative, it has been found locally expressed in the central nervous system. This article aims to describe the role of thrombin in the normal functioning of the central nervous system and stroke.
Methods: In this mini-review, the specialized databases Medscape, PubMed, and Web of Science, from the years 2003-2018, were used to find relevant documents by using MeSH terms: "thrombin" and "stroke".
Results: Prothrombin and thrombin influence neural development, protection and regeneration, thrombin being a relatively strong regulating factor of brain function. However, high levels of thrombin are detrimental to neuronal health, and cause atherosclerotic plaque development and instability - a leading cause of cerebral infarction. In stroke, thrombin promotes direct cellular toxicity, vascular disruption, oxidative stress and inflammatory response. There is a direct correlation between thrombin activity in the affected brain hemisphere and the infarction volume. Direct acting thrombin inhibitors, like dabigatran, significantly decrease the risk of ischemic stroke.
Conclusion: Further studies on the correlation between thrombin levels, generation and activity and the risk and recurrence of ischemic cerebral stroke should give new insight on this association, resulting in an optimized practical therapeutic approach.